Pharmaceutical / Drug Definition :
Selectively blocks beta1-adrenergic (myocardial) receptors; decreases cardiac output, peripheral resistance, and myocardial oxygen consumption. Also depresses renin secretion without affecting beta2-adrenergic (pulmonary, vascular, uterine) receptors.
In the United States, Atenolol is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Atenolol.
Registrar Corp assists Atenolol companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Atenolol (Atenolol Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Atenolol (Atenolol Suppliers)
- Processors Atenolol
- Repackers Atenolol
- Relabelers Atenolol
- Exporters Atenolol
- Importers Atenolol
For more information about Atenolol, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.